MedTrace Logo

SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners

NCT07481344 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2026-04-24

No results posted yet for this study

Summary

Participants will be randomly assigned to either the intervention or control group using concealed allocation. The intervention-comprising targeted educational materials and behavioral prompts-will be delivered over three months preceding race day.

All study participants will be required to complete the pre-race survey prior to the intervention. The intervention group will complete the SunBeast Educational module once and receive monthly reinforcement messages leading into race day. The SunBeast Educational Program module consists of a 30-minute live, interactive online discussion and infographics/videos on skin cancer, UV index awareness, sunscreen use, protective clothing, and timing of runs. The control group will receive a general wellness brochure via email. The general wellness brochure will contain UV protection information but will also have other general wellness topics.

Conditions

  • Sun Protection

Interventions

OTHER

SunBeast Educational module

consists of a 30-minute live, interactive online discussion and infographics/videos on skin cancer, UV index awareness, sunscreen use, protective clothing, and timing of runs.

OTHER

Control

general wellness brochure via email

Sponsors & Collaborators

  • University of Michigan Rogel Cancer Center

    lead OTHER

Principal Investigators

  • Scott Mclean, MD · University of Michigan Rogel Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-05-31
Primary Completion
2027-05-31
Completion
2027-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07481344 on ClinicalTrials.gov